Drug Profile
AGS 005
Alternative Names: AGS-005Latest Information Update: 15 Jul 2019
Price :
$50
*
At a glance
- Originator Argos Therapeutics Inc
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Cell replacements; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic lymphocytic leukaemia
Most Recent Events
- 01 Jul 2019 Kyowa Hakko Kirin is now called Kyowa Kirin
- 31 Dec 2013 Discontinued - Phase-I/II for Chronic lymphocytic leukaemia in Canada (unspecified route)
- 01 Oct 2008 Kirin Pharma Company has merged with Kyowa Hakko to form Kyowa Hakko Kirin